Guo JQ - Search Results

1

Tyrosine phosphorylation of CRKL in Philadelphia+ leukemia.

ten Hoeve J, Arlinghaus RB, Guo JQ, Heisterkamp N, Groffen J. ten Hoeve J, et al. Among authors: guo jq. Blood. 1994 Sep 15;84(6):1731-6. Blood. 1994. PMID: 7521685 Free article.

2

Detection of BCR-ABL proteins in blood cells of benign phase chronic myelogenous leukemia patients.

Guo JQ, Wang JY, Arlinghaus RB. Guo JQ, et al. Cancer Res. 1991 Jun 1;51(11):3048-51. Cancer Res. 1991. PMID: 2032243

3

BCR-ABL protein expression in peripheral blood cells of chronic myelogenous leukemia patients undergoing therapy.

Guo JQ, Lian JY, Xian YM, Lee MS, Deisseroth AB, Stass SA, Champlin RE, Talpaz M, Wang JY, Arlinghaus RB. Guo JQ, et al. Blood. 1994 Jun 15;83(12):3629-37. Blood. 1994. PMID: 8204887 Free article.

4

Tyrosine phosphorylation of P160 BCR by P210 BCR-ABL.

Lu D, Liu J, Campbell M, Guo JQ, Heisterkamp N, Groffen J, Canaani E, Arlinghaus R. Lu D, et al. Among authors: guo jq. Blood. 1993 Aug 15;82(4):1257-63. Blood. 1993. PMID: 8353288 Free article.

5

A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia.

Hochhaus A, Reiter A, Skladny H, Melo JV, Sick C, Berger U, Guo JQ, Arlinghaus RB, Hehlmann R, Goldman JM, Cross NC. Hochhaus A, et al. Among authors: guo jq. Blood. 1996 Sep 15;88(6):2236-40. Blood. 1996. PMID: 8822944 Free article.

6

Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.

Guo JQ, Hirsch-Ginsberg CF, Xian YM, Stass SA, Champlin RE, Giralt SA, McCredie KB, Campbell ML, Arlinghaus RB. Guo JQ, et al. Hematol Pathol. 1993;7(2):91-106. Hematol Pathol. 1993. PMID: 8340287

7

Inhibition of phosphorylation of p160 BCR within p210 BCR-ABL complexes during early stages of phorbol ester-induced differentiation of K562 cells.

Campbell ML, Lu D, Guo JQ, Arlinghaus RB. Campbell ML, et al. Among authors: guo jq. Cell Growth Differ. 1993 Jul;4(7):581-8. Cell Growth Differ. 1993. PMID: 8398898

8

BCR-ABL tyrosine kinase is autophosphorylated or transphosphorylates P160 BCR on tyrosine predominantly within the first BCR exon.

Liu J, Campbell M, Guo JQ, Lu D, Xian YM, Andersson BS, Arlinghaus RB. Liu J, et al. Among authors: guo jq. Oncogene. 1993 Jan;8(1):101-9. Oncogene. 1993. PMID: 8423987

9

Comparison of bcr-abl protein expression and Philadelphia chromosome analyses in chronic myelogenous leukemia patients.

Guo JQ, Lian J, Glassman A, Talpaz M, Kantarjian H, Deisseroth AB, Arlinghaus RB. Guo JQ, et al. Am J Clin Pathol. 1996 Oct;106(4):442-8. doi: 10.1093/ajcp/106.4.442. Am J Clin Pathol. 1996. PMID: 8853030

10

Evidence for specific immune response against P210 BCR-ABL in long-term remission CML patients treated with interferon.

Oka T, Sastry KJ, Nehete P, Schapiro SJ, Guo JQ, Talpaz M, Arlinghaus RB. Oka T, et al. Among authors: guo jq. Leukemia. 1998 Feb;12(2):155-63. doi: 10.1038/sj.leu.2400919. Leukemia. 1998. PMID: 9519777 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters